WEHI Special Seminar hosted by Dr Leigh Coultas

Dr Chris Francis

Senior Vice President of Corporate Development

Head of Emerging Areas at Wave Life Sciencesc 

Hear from a leader in RNA therapeutics

Davis Auditorium

Join via TEAMS

Including Q&A session

RNA based medicines are rapidly becoming a centerpiece in the prevention and treatment of diseases.

Chris will provide an overview of some of the major mechanisms involved in RNA therapeutics and key principles associated with the rational design of oligonucleotide therapeutics using these mechanisms. The presentation will focus on foundational improvements to RNA chemistry and design, advanced by Wave Life Sciences, with an emphasis on how these advances are creating new opportunities to intervene in disease biology.

Dr Chris Francis is currently the Senior Vice President of Corporate Development and Head of Emerging Areas at Wave Life Sciences, an emerging leader in RNA therapeutics. In this role he has led multiple major collaborations with pharmaceutical companies and contributed to the discovery and development of potential first-in-class medicines. Prior to Wave, Dr Francis was the head of Academic Licensing and Strategic Alliances, and head of Business Development for GSK Cancer Research. He began his career in pharmaceutical pricing and reimbursement consulting with IMS Health (now IQVIA) and building biotechnology companies at Two River Group. He received a BSc (Hons) and PhD in biochemistry and molecular biology from the University of Melbourne.

All welcome!